Publication | Closed Access
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
88
Citations
30
References
2012
Year
Tenofovir with either boosted protease inhibitor leads to a greater initial decline in eGFR than tenofovir with efavirenz; this decline may be worse with ATV/r than with LPV/r.
| Year | Citations | |
|---|---|---|
2009 | 25K | |
1976 | 15.3K | |
2006 | 5.7K | |
2000 | 5.4K | |
1998 | 5.2K | |
2008 | 2.6K | |
2000 | 1.7K | |
2010 | 403 | |
2009 | 351 | |
2002 | 343 |
Page 1
Page 1